A G E N D A 1. APOLOGIES FOR ABSENCE Ian Metcalfe 2 ...

More documents

Recommendations

Info

Board of Directors – Part I14 th June 2013There are sections in the guidance on record keeping and the opportunity forcommissioners to obtain support from Commissioning Support Units or from othersources such as the private or voluntary sectors.Conflicts of InterestThere is a significant section on conflicts of interest, in particular where individuals areinvolved in commissioning and potentially the provision of a service. The documentrecognises that this can be direct or indirect and financial or non-financial. It alsorecognises that can affect all stages of a procurement process from specificationdevelopment to contract award.Other than excluding conflicted individuals from the procurement process there are otherways suggested, including use of out of area GPs or independent lay persons. It alsosuggests that decisions taken could be subject to an independent review by a third partyand that the processes of how these are being managed should be full recorded.Anti-Competitive BehaviourThere is a short section on anti-competitive behaviour by commissioners. The process forMonitor assessing whether a commissioner has acted anti-competitively envisagesweighing the costs and the benefits of the commissioner’s procurement process andassessing the net effects of these on users of health care services. Monitor may considerwhether a commissioner has:• “…limited the extent to which providers are able to compete by limiting the totalnumber of patients a provider can treat or income a provider can earn…”• “…restricted the ability of providers to differentiate themselves to attract patients,such as, for example, by imposing minimum waiting times that providers must adhereto or restricted opening hours, without objective justification…”The final section of the Compliance document relates to the commissioner responsibility tooffer patient choice. The part of this that affects us relates to maximum waiting times inelective care. This supports existing requirements such that where a patient that hasbeen referred for elective care will not have commenced treatment within 18 weeks of areferral being received the commissioners are required to take all reasonable steps toensure that a patient is offered an appointment with a clinical appropriate alternativeprovider.3. Enforcement of the RegulationsThe other guidance published in addition to the above is the enforcement guidanceassociated with the same Procurement, Patient Choice and Competition Regulations.This covers the steps that Monitor would take on being informed of a potential breach ofthe guidance by a commissioner. These steps include;Monitor Guidance on Procurement Patient Choice and Competition Regulations Page 3 of 4For Information
Board of Directors – Part I14 th June 2013• Prioritisation –which cases Monitor would pursue and to what extent - based on thelikely benefits to health care service users and including the likely costs of takingaction• Making a “Declaration of Ineffectiveness” – this encompasses making “Directions” [toa commissioner] such as varying or withdrawing a tender or otherwise directing acommissioner• Accepting undertakings from commissioners in response to a “Direction” or to avoid a“Declaration of Ineffectiveness”4. RecommendationThe Board is asked to note this report for informationMonitor Guidance on Procurement Patient Choice and Competition Regulations Page 4 of 4For Information
Page 1 and 2:
A meeting of the Board of Directors
Page 3 and 4:
THE ROYAL BOURNEMOUTH AND CHRISTCHU
Page 5 and 6:
In response to a question from KT a
Page 7 and 8:
how this was being rolled out throu
Page 9 and 10:
still challenged at times;• that
Page 11 and 12:
(c)Stroke Performance (Presentation
Page 13 and 14:
• nurse staffing was already bein
Page 15 and 16:
(b) Informatics Strategy (Appendix
Page 17 and 18:
(b)Monitor’s Guidance for NHS Pro
Page 19 and 20:
THE ROYAL BOURNEMOUTH AND CHRISTCHU
Page 21 and 22:
BOARD OF DIRECTORSMeeting Date and
Page 23 and 24:
Quality Impact Assessments 2013/14T
Page 26 and 27:
Example of completed QIATransformat
Page 28 and 29:
Board of Directors Part 114th June
Page 30 and 31:
Board of Directors Part 114th June
Page 32 and 33:
Area Indicator Measure Target Monit
Page 34 and 35:
Trust Performance Dashboard - Quali
Page 36 and 37:
Board of DirectorsJune 2013Financia
Page 38 and 39:
Board of DirectorsJune 20138. Recom
Page 40 and 41:
BOARD OF DIRECTORSMeeting Date and
Page 42 and 43:
Board of Directors Part 114 June 20
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
EnforcementGuidance28 March 2013Mon
Page 84 and 85:
ForewordThe Health and Social Care
Page 86 and 87: 1 IntroductionThe Health and Social
Page 88 and 89: Table 1.1 Monitor’s enforcement p
Page 90 and 91: Licence enforcementDiscretionary re
Page 92 and 93: Competition lawMonitor has concurre
Page 94 and 95: 2 PrioritisationThis chapter sets o
Page 96 and 97: We also recognise that the actions
Page 98 and 99: 3 Imposing discretionary requiremen
Page 100 and 101: SeriousnessMonitor will take into a
Page 102 and 103: Deterring similar breaches by other
Page 104 and 105: An important objective of imposing
Page 106 and 107: 4 Enforcement - case procedures4.1
Page 108 and 109: provide regular case updates to par
Page 110 and 111: including in the application eviden
Page 112 and 113: In certain circumstances, Monitor m
Page 114 and 115: Non-compliance penaltiesUnder sched
Page 116 and 117: Notice of Intent (section 90)Where
Page 118 and 119: • any incidental or consequential
Page 120 and 121: Monitor will have concurrent powers
Page 122 and 123: the first two decision-making point
Page 124 and 125: Non-compliance penaltiesA provider
Page 126 and 127: AnnexMonitor’s powers of enforcem
Page 128 and 129: a) has provided, or is providing, a
Page 130 and 131: c) the matters likely to be taken i
Page 132 and 133: Monitor, 4 Matthew Parker Street, L
Page 134 and 135: Board of Directors - Part I14 th Ju
Page 142 and 143: Board of Directors Part I14 th June
Page 144 and 145: Board of Directors Part I14 th June
Page 146 and 147: BOARD OF DIRECTORSMeeting Date and
Page 148 and 149: Job DescriptionPOST TITLEREPORTS AN
Page 150 and 151: MEDICAL LEADERSHIPAs Medical Direct
Page 152 and 153: PERSON SPECIFICATIONQualifications:
Page 154 and 155: CALDICOTT GUARDIAN ROLE DESCRIPTION
Page 156 and 157: BOARD OF DIRECTORSMeeting Date and
Page 158 and 159: Transporting sharps containersIn or
Page 160 and 161: NHS Winter Heroes recognisedFour me
Page 162 and 163: Leadership programmesSupported by N
Page 164 and 165: Board of Directors - Part I14 June
Page 166 and 167: Board of Directors - Part I14 June
Page 168 and 169: DatePublicationTitleInformationPage
Page 170 and 171: DatePublicationTitle3 May 2013www.s
Page 172 and 173: May 2013 l 6
Page 180 and 181: DatePublicationTitle13 May 2013www.
Page 184 and 185: DatePublicationTitle14 May 2013www.
Page 186 and 187:
DatePublicationTitleInformationPage
Page 188 and 189:
DatePublicationTitle20 May 2013www.
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Board of Directors Business Program
show all

A G E N D A 1. APOLOGIES FOR ABSENCE Ian Metcalfe 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?